In order to address the clinical relevance of GILZ–CCL2 axis in human LF, we analyzed GILZ mRNA expression in RNAseq data obtained from NASH and NAFLD patient liver samples63,64. The gene discussed is TSC22D3; the disease is metabolic dysfunction-associated steatohepatitis.